The following new grants were awarded to JCCC members in June 2011:
Principal Investigator: Kenneth Bradley
Sponsor Name: Melanoma Research Alliance
Award Title: "Repurposing Anthrax Toxin for Imaging and Treatment of Melanoma"
Principal Investigator: E. R. Brown
Sponsor Name: CA/Department of Mental Health
Award Title: "California Health Interview Survey (CHIS) 2011-2012"
Principal Investigator: Steven Dubinett
Sponsor Name: NIH/National Center for Research Resources
Award Title: "UCLA Clinical and Translational Science Institute"
Principal Investigator: Steven Dubinett
Sponsor Name: NIH/National Center for Research Resources
Award Title: "UCLA Clinical and Translational Science Institute"
Principal Investigator: Richard Finn
Sponsor Name: iomarin Pharmaceuticals Inc.
Award Title: "UCLA-Biomarin PARP Pre-Clinical Collaboration"
Principal Investigator: John Glaspy
Sponsor Name: Celgene Corporation
Award Title: "A Single-Blind, Randomized, Phase 2A, Dose Ranging Study (Part 1) of Ace-011 Therapy Followed by A Phase 2B/3, Double-Blind, Randomized, Placebo-Controlled Study (Part 2) of Ace-011 for Chemotherapy Induced Anemia (Cia) In Subjects With Metastatic Non-Small Cell Lung Cancer (Nsclc) Treated with First-Line Platinum-Based Chemotherapeutic Regimens"
Principal Investigator: Anthony Heaney
Sponsor Name: P Novartis Pharmaceuticals / Novartis AG (incl. Pharma, Animal HL)
Award Title: "A Phase 3, Multicenter, Radomized, Parallel-Group Study to Assess the Efficacy and Safety of Double-Blind Pasireotide LAR 40 Mg and Pasireotide LAR 60"
Principal Investigator: Shen Hu
Sponsor Name: Sjogren"S Syndrome Foundation
Award Title: "Ifn-Gamma Induces Immunoproteasome in Human Salivary Gland Cells"
Principal Investigator: Sara Hurvitz
Sponsor Name: Boehringer Ingelheim Pharmaceuticals, Inc.
Award Title: "LUX-Breast 1; An Open Label, Randomised Phase Iii Trial of BIBW 2992 and Vinorelbine Versus Trastuzumab and Venorelbine in Patients with Metastatic HER2-Overexpressing Breast Cancer Failing One Prior Trastuzumab Treatment "
Principal Investigator: Albert Lai
Sponsor Name: American Brain Tumor Association
Award Title: "Mechanisms of Glioblastoma Radiosensitization and Tumor Suppression by Mutant Isocitrate Dehydrogenase 1 (Idh1)"
Principal Investigator: Roger S. Lo
Sponsor Name: Sidney Kimmel Cancer Center (incl. Sidney Kimmel Cancer Center FDN)
Award Title: "Exome Sequencing of Melanomas with Acquired Resistance to BRAFInhibitors"
Principal Investigator: Karen Lyons
Sponsor Name: NIH/Natl Institute of Arthritis & Musculoskeletal & Skin Diseases
Award Title: "Hall-Glenn: Role of CCN2 in Matrix Secretion and Cellular Stress During Cartilage Development"
Principal Investigator: Sally Maliski
Sponsor Name: NIH/National Institute of Nursing Research
Award Title: "Underserved Men's Understanding of Andgrogen Deprivation Therapy-Related Risks"
Principal Investigator: Heather Maynard
Sponsor Name: National Science Foundation
Award Title: "Glycopolymers for Protection of Protein Conjugates"
Principal Investigator: Paul Mischel
Sponsor Name: The Ben And Catherine Ivy Foundation
Award Title: "Brain Cancer Molecular Diagnostics Translational Medicine Laboratory"
Principal Investigator: Paul Mischel
Sponsor Name: NIH/National Institute of Neurological Disorders & Stroke
Award Title: "Role of MTORC2 In GBM-Development of A Novel Therapeutic MTOR Kinase Inhibitor"
Principal Investigator:
Allan Pantuck
Sponsor Name: Dresden University Of Technology (Germany)
Award Title: "Creation of a Second Generation In Vivo Genetically Modified Kidney Cancer Vaccine Based Dendritic Cell Targeting Lenti-DC Sign Vector Gmcaix Fusion Protein"
Principal Investigator: Dinesh S. Rao
Sponsor Name: Sidney Kimmel Cancer Center (incl. Sidney Kimmel Cancer Center FDN)
Award Title: "Unraveling the Role of Microrna In Hematolymphoid Malignancy"
Principal Investigator: Antoni Ribas
Sponsor Name: The Melanoma Research Foundation
Award Title: "Understanding of CTLA4 Blockade and its Combination With BRAF Inhibition"
Principal Investigator: Gary Schiller
Sponsor Name: Sunesis Pharmaceuticals, Inc.
Award Title: "A Phase 3, Randomized, Controlled, Double-Blind, Multinational Clinical Study of the Efficacy and Safety of Vosaroxin and Cytarabine Versus Placebo and Cytarabine In Patients with First Relapsed or Refractory Acute Myeloid Leukemia (VALOR)"
Principal Investigator: Peter Tontonoz
Sponsor Name: American Heart Association (Western States Affiliate)
Award Title: "Metabolism and Atherosclerosis In Idol Knockout Mice (Fellow: Ayaka Ito)"